QUALITY OF RAC SCIENTIFIC REVIEW OF GENE THERAPY PROTOCOLS QUESTIONED BY NIH DIRECTOR VARMUS AT AD HOC PANEL; HE SUGGESTS CENTERS FOR EXCELLENCE
Executive Summary
The scientific review process of gene therapy protocols as conducted by the National Institutes of Health Recombinant DNA Advisory Committee is in need of close evaluation, NIH Director Harold Varmus, MD, said at the first meeting of the ad hoc review committee of the RAC Feb. 3.